AU1559197A - Vaccine prepared using human-origin hantaan virus nucleocapsid protein expressed from escherichia coli - Google Patents

Vaccine prepared using human-origin hantaan virus nucleocapsid protein expressed from escherichia coli

Info

Publication number
AU1559197A
AU1559197A AU15591/97A AU1559197A AU1559197A AU 1559197 A AU1559197 A AU 1559197A AU 15591/97 A AU15591/97 A AU 15591/97A AU 1559197 A AU1559197 A AU 1559197A AU 1559197 A AU1559197 A AU 1559197A
Authority
AU
Australia
Prior art keywords
origin
human
escherichia coli
protein expressed
nucleocapsid protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15591/97A
Inventor
Sun Pyo Hong
Hyun Su Kim
Soo Ok Kim
Sung Hee Lee
Kap Soo Noh
Young Chol Shin
Wang Don Yoo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CJ Corp
Original Assignee
CJ Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019960001638A external-priority patent/KR0178110B1/en
Application filed by CJ Corp filed Critical CJ Corp
Publication of AU1559197A publication Critical patent/AU1559197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12111—Hantavirus, e.g. Hantaan virus
    • C12N2760/12122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU15591/97A 1996-01-25 1997-01-25 Vaccine prepared using human-origin hantaan virus nucleocapsid protein expressed from escherichia coli Abandoned AU1559197A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR961638 1996-01-25
KR1019960001638A KR0178110B1 (en) 1995-09-30 1996-01-25 Vaccine prepared from nicleocapsid protein of human derived hantaan virus expressed in e.coli
PCT/KR1997/000016 WO1997027302A1 (en) 1996-01-25 1997-01-25 Vaccine prepared using human-origin hantaan virus nucleocapsid protein expressed from escherichia coli

Publications (1)

Publication Number Publication Date
AU1559197A true AU1559197A (en) 1997-08-20

Family

ID=19450095

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15591/97A Abandoned AU1559197A (en) 1996-01-25 1997-01-25 Vaccine prepared using human-origin hantaan virus nucleocapsid protein expressed from escherichia coli

Country Status (2)

Country Link
AU (1) AU1559197A (en)
WO (1) WO1997027302A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298423A (en) * 1987-11-25 1994-03-29 The United States Of America As Represented By The Secretary Of The Army Nucleotide sequences encoding the expression of a Hantaan virus nucleocapsid protein and G1 and G2 glycoproteins
KR900007952B1 (en) * 1988-11-18 1990-10-23 주식회사 녹십자 Novel hantaan virus and method for preparation of its vaccine
JP3809502B2 (en) * 1995-05-30 2006-08-16 二郎 有川 Hantavirus antigen protein and monoclonal antibody

Also Published As

Publication number Publication date
WO1997027302A1 (en) 1997-07-31

Similar Documents

Publication Publication Date Title
AU4071595A (en) Live recombinant avian vaccine using an avian herpesvirus as vector
AU3448797A (en) Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
AU6217798A (en) Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
AU5562798A (en) Recombinant live avian vaccine, using as vector the avian infectious laryngotracheitis virus.
AU3574897A (en) Aqueous formulations of peptides
AUPO066096A0 (en) Oral delivery of peptides
AU3910097A (en) Live recombinant vaccine comprising inefficiently or non-replicating vir us
AU6093296A (en) Infectious dengue 2 virus pdk-53 as quadravalent vaccine
AU3119895A (en) Recombinant virus vectors
AU5681094A (en) Protein hydrolysate derived from mucosal tissue
AU3328900A (en) Influenza virus hemagglutinin-binding peptides
AU2562897A (en) Pathogenic (escherichia coli) associated protein
AU1508699A (en) Live attenuated influenza vaccine
AU6109990A (en) Escherichia coli vaccine
AU2328397A (en) Recombinant live feline immunodeficiency virus and proviral dna vaccines
AU7077898A (en) Recombinant vectors derived from adeno-associated virus suitable for gene therapy
AU4553697A (en) Immunogenic peptides of foot-and-mouth disease viruses
AU6858594A (en) Human influenza virus peptides binding hla-t molecule
AUPO026596A0 (en) Viral peptide
AUPQ233799A0 (en) Recombinant sub-unit vaccine
AU3058897A (en) Attenuated canine parvovirus vaccine
AU1559197A (en) Vaccine prepared using human-origin hantaan virus nucleocapsid protein expressed from escherichia coli
AU6715094A (en) Recombinant vaccine
AU5597998A (en) Recombinant plague vaccine
AU4489896A (en) Avian recombinant live vaccine